NCT01422369View on ClinicalTrials.gov

Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Healthy
Interventions
DRUG

Pitavastatin (NK-104)

Pitavastatin (NK-104) 4mg once daily (QD)

DRUG

Darunavir/Ritonavir (Prezista)

Darunavir/Ritonavir (Prezista) 800 mg/100 mg

Trial Locations (1)

Unknown

Austin

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY